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Although analysis of toxin-antitoxin (TA) systems can be instructive, to date, there is no information on the preva-
lence and identity of TA systems based on a large panel of Acinetobacter baumannii clinical isolates. The aim of the 
current study was to screen for functional TA systems among clinical isolates of A. baumannii and to identify the sys-
tems’ locations. For this purpose, we screened 85 A. baumannii isolates collected from different clinical sources for 
the presence of the mazEF, relBE and higBA TA genes. The results revealed that the genes coding for the mazEF TA 
system were commonly present in all clinical isolates of A. baumannii. Reverse transcriptase-polymerase chain reac-
tion analysis showed that transcripts were produced in the clinical isolates. Our findings showed that TA genes are 
prevalent, harboured by chromosomes and transcribed within A. baumannii. Hence, activation of the toxin proteins in 
the mazEF TA system should be investigated further as an effective antibacterial strategy against this bacterium.
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The use of antibiotics for the treatment of infection in 
humans and animals over the past decades has led to the 
evolution of multiple drug resistance in microbes. Resis-
tance to antibiotics develops through mutations of target 
sites or the acquisition of antibiotic-resistant genes from 
other pathogens. To date, multiple drug resistance has 
been the greatest challenge in the management of infec-
tious diseases. Although studies on the development of 
new antibiotics are rapidly progressing, the identifica-
tion of new drug targets in microbes is also very impor-
tant for effective infection control. Currently, resistance 
to antimicrobial agents seems to be a problematic issue 
worldwide. Thus, finding new antibiotics as a strategy 
to continue antibiotic therapy seems urgent (Davies & 
Webb 1998, Schlessinger & Eisenstein 1999).
A toxin-antitoxin (TA) system is a set of two or more 
closely linked genes that together encode both a protein 
“poison” and a corresponding “antidote”. TA systems 
were first described in 1982 (Ghafourian et al. 2014). 
Detailed insights into their functions and mechanisms 
of action have been gained over the last two decades 
and have led to several interesting conclusions about 
the importance of such systems for bacterial physiology. 
TA systems consist of a toxin and an antitoxin protein; 
when expressed, the toxin kills the bacterium. In typi-
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cal bacterial physiology, the antitoxin binds to the toxin 
and neutralises it, hence preventing the suicide of the 
bacterium. The toxin protein is always stable, whereas 
the antitoxin is unstable. The unstable nature of the anti-
toxin makes it highly susceptible to proteolytic degrada-
tion. When the antitoxin is degraded or not functional, 
the toxin produced kills the bacterium, which is known as 
programmed cell death (Cherny 2007). Thus, this system 
has recently gained attention, especially as a target for an-
timicrobial agents. However, the presence and type of TA 
system vary from bacterium to bacterium. TA systems can 
be either plasmid encoded or chromosomally mediated. In 
plasmid-mediated systems, if the plasmid is lost during 
cell division, the antitoxin protein rapidly degrades and is 
not replenished. The stable toxin is thus released, killing 
the bacterial cell (Gerdes 1986, Gerdes et al. 2005).
In the present investigation, we aimed to screen 
for different TA systems in Acinetobacter baumannii. 
Acinetobacter species are top ranking among nosocomi-
al pathogens with multiple drug-resistant strains. These 
species cause various nosocomial infections, such as 
bacteraemia, urinary tract infection, secondary menin-
gitis, surgical site infection and nosocomial and ventila-
tor-associated pneumonia (Go et al. 1994). The manage-
ment of Acinetobacter infections is always challenging, 
especially in intensive care units, with many mortality 
reports. Identifying the types of TA systems, whether 
they are functional and their location in A. baumannii 
will provide a fundamental understanding of their ap-
plication as antibiotic targets.
Eighty-five unique multidrug-resistant A. baumannii 
isolates isolated from different clinical sources in Ma-
laysia were investigated. All isolates were subjected to 
amplification of the mazEF, relBE and higBA TA genes 
within chromosomal and plasmid DNA using primers 
designed based on the corresponding gene sequence 
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in the gene bank (Table I). Polymerase chain reaction 
(PCR) amplification was performed in a DNA thermal 
cycler (Bio-Rad) using the amplification parameters de-
scribed previously (Moritz & Hergenrother 2007), with 
a lowering of the annealing temperature to 58ºC. The 
PCR-amplified products were analysed by agarose gel 
electrophoresis. To identify whether the TA systems 
were encoded in plasmid or chromosomal DNA, PCR 
amplification for all isolates was conducted individu-
ally with plasmid and chromosomal DNA. To assess 
functionality, reverse transcriptase (RT)-PCR was per-
formed using the SuperScript One-Step RT-PCR System 
with Platinum Taq (Invitrogen). The reverse transcrip-
tion and PCR amplification were conducted in a DNA 
thermal cycler (Bio-Rad) under the reaction conditions 
described previously (Moritz & Hergenrother 2007), us-
ing the primers used for the conventional PCR described 
above. The RT-PCR amplification products were analy-
sed by agarose gel electrophoresis.
The results of screening chromosomal DNA for the 
presence of different TA loci showed that all A. bau-
mannii isolates (85/85, 100%) were positive for mazEF 
and that relBE was found in 88.2% of isolates (75/85), 
whereas higBA (4/85, 4.7%) was less prevalent (Table II). 
PCR analysis of plasmid DNA did not yield any posi-
tive amplification, indicating that in A. baumannii, the 
screened TA systems were chromosomally mediated. To 
confirm the functionality of the TA systems, all clinical 
isolates containing TA systems were subjected to RT-
PCR. RNA from all isolates was collected and subjected 
to cDNA synthesis. PCR was then performed to confirm 
the functionality of the TA systems. The positive results 
confirmed the functionality of the TA systems.
TA system transcripts were detected from the total 
RNA of all A. baumannii strains probed by RT-PCR. 
The results of the RT-PCR strongly indicated that the 
TA systems are functional in all A. baumannii. To con-
trol for the contamination of any reaction with DNA, a 
TABLE I
Gene-specific primers used for polymerase chain reaction (PCR) and reverse transcriptase-PCR analysis
Toxin-antitoxin systems Primer sequences Length
mazEF Forward: ACCTTCGAAGGAACTACGTCAGTAGReverse: ATAGGCGAACATGCAAGAAAAGGCAGC 436 bp
relBE Forward: ATGAAGTGAACGGTCAACAATAReverse: ACAGACCTCGGAAAGTGGTCG 578 bp
higBA Forward: AGCACATCCGTACGATCTACTGC-3Reverse: TGCACTCCTGCGATGCGGCGAA 440 bp
TABLE II
Prevalence of different toxin-antitoxin loci in Acinetobacter baumannii







1 + - - + - -
2 + - + + - +
3 + - + + - +
4 + - + + - +
5 + - + + - +
6 + - + + - +
7 + - + + - +
8 + - + + - +
9 + - - + - -
10 + - + + - +
11 + - + + - +
12 + + + + + +
13 + - + + - +
14 + - + + - +
15 + - + + - +
16 + - + + - +
17 + - - + - -
18 + - - + - -
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19 + - + + - +
20 + - + + - +
21 + + + + + +
22 + + + + + +
23 + - + + - +
24 + - + + - +
25 + - + + - +
26 + - + + - +
27 + - + + - +
28 + - + + - +
29 + - + + - +
30 + - + + - +
31 + - + + - +
32 + - - + - -
33 + - + + - +
34 + - + + - +
35 + - + + - +
36 + - + + - +
37 + - + + - +
38 + - + + - +
39 + - + + - +
40 + - - + - -
41 + - + + - +
42 + - + + - +
43 + - + + - +
44 + - + + - +
45 + + + + + +
46 + - + + - +
47 + - - + - -
48 + - - + - -
49 + - + + - +
50 + - + + - +
reaction without the RT enzyme, but including the other 
materials, was used. The negative results confirmed that 
no contamination of the DNA had occurred. In a study 
on Escherichia coli and the cyanobacterium Anabaena 
by Ning et al. (2013), similar results were obtained, 
which showed the functionality of the mazEF TA sys-
tem. Moritz and Hergenrother (2007) demonstrated the 
functionality of mazEF using RT-PCR by evaluating 
10 vancomycin resistance enterococcus (VRE) isolates 
and found that mazEF TA loci were transcribed in all 10 
VRE isolates. We used PCR as a tool to screen for differ-
ent TA systems in A. baumannii and found that mazEF 
TA loci were frequently present.
Identifying TA systems in clinical isolates is impor-
tant for validating these systems as antibacterial targets. 
In the current study, RT-PCR analysis was performed to 
determine whether the TA systems were transcribed. RT-
PCR showed that the mazEF, higBA and relBE TA sys-
tems were functional in all strains positive for TA loci.
It has been suggested that by activating TA systems 
(disrupting antitoxin or causing increased toxin expres-
sion), it is possible to find a new sensitive target in A. 
baumannii (Engelberg-Kulka et al. 2004, Gerdes et al. 
2005, Williams & Hergenrother 2008). Unfortunately, no 
previous study has examined the prevalence of TA sys-
tems in a large panel of clinical isolates of A. baumannii. 
In addition, this is the first time that the mazEF, higBA 
and relBE transcripts have been shown to be present in 
A. baumannii and one of the few examples demonstrating 
the transcription of any TA loci in a clinical isolate.
The current research indicated that TA systems are 
prevalent, harboured by chromosomes and transcribed 
in clinical isolates of A. baumannii.
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